Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker

被引：0
|
作者：
Yingting Xu
Zhengjun Lin
Yuqiao Ji
Chen Zhang
Xianzhe Tang
Chuan Li
Tang Liu
机构：
[1] The Second Xiangya Hospital,Department of Orthopedics
[2] Central South University,Department of Orthopaedic
[3] 920Th Hospital of Joint Logistics Support Force of Chinese People’s Liberation Army,Department of Orthopedics
[4] Chenzhou No.1,Department of The Emergency
[5] People’s Hospital,undefined
[6] The Fourth People’s Hospital of Zigong,undefined
来源：
European Journal of Medical Research | / 28卷
关键词：
RNF43; Pan-cancer; Immunotherapeutic efficacy; Prognostic biomarker; Immune microenvironment; Genetic alternations; Drug sensitivity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
    Xu, Yingting
    Lin, Zhengjun
    Ji, Yuqiao
    Zhang, Chen
    Tang, Xianzhe
    Li, Chuan
    Liu, Tang
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [2] Systematic pan-cancer analysis identifies cGAS as an immunological and prognostic biomarker
    Chen, Peng
    Yang, Xian
    Wang, Peiyuan
    He, Hao
    Chen, Yujie
    Yu, Lingfeng
    Fang, Huipeng
    Wang, Feng
    Huang, Zhijian
    ANNALS OF TRANSLATIONAL MEDICINE, 2023,
  • [3] Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker
    Li, Jiayi
    Hou, Haiguang
    Sun, Jinhao
    Ding, Zhaoxi
    Xu, Yingkun
    Li, Guibao
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23 (02)
  • [4] A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker
    Huang, Yangqing
    Zhou, Xinlan
    Li, Xiufen
    Huang, Dan
    Fang, Zhong
    Ding, Rongrong
    ONCOLOGY RESEARCH, 2023, 31 (02) : 193 - 205
  • [5] A pan-cancer analysis identifies HDAC11 as an immunological and prognostic biomarker
    Li, Ran
    Wu, Xiaolu
    Zhao, Ping
    Xue, Kai
    Li, Junmin
    FASEB JOURNAL, 2022, 36 (07):
  • [6] Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker
    Yang, Yaqi
    Liu, Qin
    Guo, Xiyuan
    Yuan, Qing
    Nian, Siji
    Kang, Pengyuan
    Xu, Zixi
    Li, Lin
    Ye, Yingchun
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [7] A systematic pan-cancer analysis identifies RIOK3 as an immunological and prognostic biomarker
    Li, Jian
    Sun, Ruili
    He, Lixiang
    Sui, Guoyi
    Di, Wenyu
    Yu, Jian
    Su, Wei
    Pan, Zenggang
    Zhang, Yu
    Zhang, Jinghang
    Ren, Feng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (06): : 3750 - +
  • [8] Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker
    Zhang, Rui
    Wang, Wei
    Zhang, Nie
    Chen, Xueting
    Liu, Wanming
    Zhang, Longzhen
    Liu, Nianli
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (18) : 4859 - 4871
  • [9] Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
    Cheng, Xin
    Wang, Xiaowei
    Nie, Kechao
    Cheng, Lin
    Zhang, Zheyu
    Hu, Yang
    Peng, Weijun
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
    Zhang, Fang
    Wang, Yali
    Li, Hongjuan
    Li, Li
    Yang, Xiaofeng
    You, Xiaoyan
    Tang, Lina
    FRONTIERS IN ONCOLOGY, 2023, 13
12345